Skip to main content

Tevis Investment Management

Position in NVO — Novo Nordisk A S

CIK 1940416 PLANO, TX

Position in NVO

as of Jun 30, 2026 · filed Aug 6, 2026
Position Value
$3,601,013
+$878,206 QoQ
Shares Held
75,115
+1.4% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
2.00%
of 13F equity value
Holder Rank
#265
of 1,348 holders
Holding Since
Dec 2021
19 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in NVO Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

Tevis Investment Management holds $14,056,408 across 7 Drug Manufacturers - General names. NVO ranks #2 (25.6% of the industry book) .

# Ticker Company Shares Value (USD) Open
2 NVO
Novo Nordisk A S
This page
75,115 $3,601,013

All Filings in NVO

Export CSV
19 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $3,601,013 75,115
2026-03-31 $2,722,807 74,090
2025-12-31 $2,274,336 44,700
2025-09-30 $2,480,403 44,700
2025-06-30 $2,751,275 39,862
2025-03-31 $1,045,974 15,063
2024-12-31 $1,295,719 15,063
2024-09-30 $1,796,290 15,086
2024-06-30 $2,185,063 15,308
2024-03-31 $2,071,220 16,131
2023-12-31 $1,759,270 17,006
2023-09-30 $1,511,422 16,620
2023-06-30 $1,345,454 8,314
2023-03-31 $1,350,302 8,485
2022-12-31 $1,383,039 10,219
2022-09-30 $1,025,690 10,295
2022-06-30 $1,123,723 10,085
2022-03-31 $1,056,374 9,513
2021-12-31 $1,057,728 9,444